chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a healthcare worker refers to a 7 month old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 25-JAN-2016, the patient was inadvertently vaccinated with a dose of VAQTA lot # L036300, expiration date 04-NOV-2016 (dose and route of administration were not reported). There was no adverse effect reported. Additional information has been requested.
I felt like my brain and brain stem were swollen.  It took at least a week before my brain began to feel normal.
vomiting uncontrollably; acid reflux; severe headache; very achy all over; noticeable pain in jaw; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 09:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included fatty liver disease, high cholesterol and overweight. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included paracetamol (TYLENOL) and ascorbic acid; cyanocobalamin; ergocalciferol; nicotinamide; pyridoxine hydrochloride; retinol; riboflavin; thiamine mononitrate (ONE-A-DAY), both from unknown dates for unknown indications and unknown if ongoing. On 15Apr2021 at 07:00, the patient experienced severe headache, very achy all over, noticeable pain in jaw but was still able to work and function. On the same day at 21:00, the patient experienced acid reflux and 5 minutes later at 21:05, the patient was vomiting uncontrollably. The patient fell asleep at 23:00 and woke up on 16Apr2021 feeling fine, no symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache, very achy all over, noticeable pain in jaw, acid reflux and vomiting uncontrollably was recovered on 16Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Patient was given a flu shot on 10/10/2019 but shot was not completely filled out in chart so it was not visible that one had been administered. Patient came in on 12/23/19 and was given a 2nd shot with a different lot #.
skin rash; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 26-Mar-2022 Reporter's comment: This case was reported via interactive digital media. The reporter reported was it possible to developed skin rash after taking second dose of Shingles vaccine. Additional Supportive Information: The follow-up would not possible as no contact details were available.
Warm indurated injection site (Lt arm). Temp 99.8 associated w/ myalgias and chills. No other cause of infection noted.
Feeling sick/ been in bed; Dizzy; Feels bad; Right arm hurts; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling sick/ been in bed), DIZZINESS (Dizzy), FEELING ABNORMAL (Feels bad) and PAIN IN EXTREMITY (Right arm hurts) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Diabetes and Sarcoidosis.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, the patient experienced MALAISE (Feeling sick/ been in bed), DIZZINESS (Dizzy), FEELING ABNORMAL (Feels bad) and PAIN IN EXTREMITY (Right arm hurts). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, MALAISE (Feeling sick/ been in bed) had not resolved and DIZZINESS (Dizzy), FEELING ABNORMAL (Feels bad) and PAIN IN EXTREMITY (Right arm hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included blood pressure medication, diabetes injectable medication, medication for sarcoidosis and t-galopen.
heart rate increased; felt nauseous; flushed; This is a spontaneous report from a contactable consumer. A 48-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 26Jan2021 12:00 (Batch/Lot Number: EL3247) as 1st dose, single for covid-19 immunization.  The patient's medical history included rheumatoid arthritis, Hashimoto's Thyroiditis, allergies: Sulfa based drugs, shortlived anesthesia. There were no concomitant medications.  The patient previously took codeine and experienced allergies, humira and experienced allergies.  The patient experienced heart rate increased, felt nauseous, flushed on 26Jan2021 12:00 PM. The patient right after shot,her heart rate increased and she felt nauseous and very flushed. No treatment received for the adverse event. The Facility where the most recent COVID-19 vaccine was administered was Hospital.The patient underwent lab tests and procedures which included heart rate: increased on 26Jan2021 12:00 PM. The outcome of the events was recovered on unspecified date  Follow-up attempts are completed. No further information is expected.
Roughly 11 hours after the injection, 75% of my body was covered in hives.  I was very itchy and red.  The next day I did a televisit through my health insurance provider's website and saw a medical professional who advise that I treat the hives with OTC drugs like Benedryl & Pepcid.  I also used topical creams like Cortisone & Gold Bond.  I soaked in a bath with an oatmeal powder.  Also used an ice pack.  I got very little temporary relief from these treatments.  The medical profession said to not use a steroid as no one is sure what that could do to the effectiveness of the vaccine.  This has gone on now for over three full days now and I'm following up with my regular medical practice today.  The affected areas (most of my body) look slightly better today but I'm still just as itchy.  In addition, my top lip was slightly swollen when I woke up today but has since gone down.  I haven't had any respiratory issues.
On 12/9, 5 days after vaccine, pt experienced burning sensation on face just above cheek, lasting about a minute or less and then going away. Periodically over the following days she experienced the same burning sensation also lasting about a minute on her finger, then on another day under her lip. Each episode seems to be random and lasts about a minute or less then subsides.
No adverse event; received 0.2mL Bivalent dose ( Lot- 215K22A) from the pink cap vial on 28Apr2023 instead instead of the vial with a blue cap; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (received 0.2mL Bivalent dose ( Lot- 215K22A) from the pink cap vial on 28Apr2023 instead instead of the vial with a blue cap) and NO ADVERSE EVENT (No adverse event) in an infant female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 215K22A) for COVID-19 prophylaxis.     It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 28-Apr-2023, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .2 milliliter. On 28-Apr-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (received 0.2mL Bivalent dose ( Lot- 215K22A) from the pink cap vial on 28Apr2023 instead instead of the vial with a blue cap). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (received 0.2mL Bivalent dose ( Lot- 215K22A) from the pink cap vial on 28Apr2023 instead instead of the vial with a blue cap) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (received 0.2mL Bivalent dose ( Lot- 215K22A) from the pink cap vial on 28Apr2023 instead instead of the vial with a blue cap).    Concomitant medication was not provided.  Patient received MODERNA COVID-19 VACCINE (Dose 1 andAS1417B) on 22-Mar-2023. Treatment information was not provided.
Soreness in arm was achy and tired; Soreness in arm was achy and tired; Soreness in arm was achy and tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2 (BNT162B2), on 01Jun2022 at 09:00 as dose 4 (booster), single (Lot number: FL3197) at the age of 65 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ELIQUIS; ATORVASTATIN; DILTIAZEM. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 Immunization; Covid-19 vaccine (Dose 3, Unknown Manufacturer), for Covid-19 Immunization. The following information was reported: ARTHRALGIA (non-serious), PAIN (non-serious), FATIGUE (non-serious) all with onset 01Jun2022 at 20:00, outcome "recovered" (Jun2022) and all described as "Soreness in arm was achy and tired". Therapeutic measures were not taken as a result of arthralgia, pain, fatigue.  Additional information: It was reported that the patient had received no other vaccines within 4 weeks prior to covid vaccine. The patient had not diagnosed with covid prior vaccination and the patient had not tested to covid post vaccination. The patient had no known allergies.
Patient reported to me on 2/9/18 that by the evening of 02/06/2018 she was experiencing aching, throbbing, tenderness in the right arm from shoulder to wrist. She took some generic Tylenol, 325mg, and reported that by the morning of 02/07/2018 the arm was only a little tender, with minor ache, and that this subsided by noon.
Swelling, Redness, Tenderness, warmth for shoulder to elbow. Full ROM. Afebrile
Sharp pain in upper arm muscle, back, and lower arm multiple times per day. Pain continues to last and has not lessened in severity. Visited doctor, who recommended 800mg ibuprofen per day. Pain not relieved at this time.
Pt collapsed with related motor twitching, approximately 5 minutes after hep B administration (3rd injcetion). Recover with fan and cold compress, complained of nausea. Soda given and advised to eat high protein sandwich (peanut butter). Recommend seeing pediatrician.
Heart inflammation; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MYOCARDITIS (Heart inflammation) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYOCARDITIS (Heart inflammation) (seriousness criterion medically significant). At the time of the report, MYOCARDITIS (Heart inflammation) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  Treatment information was not provided.  Company Comment: Very limited information regarding this event has been provided at this time.; Sender's Comments: Very limited information regarding this event has been provided at this time.
got covid n flu as a Christmas gift; got covid n flu as a Christmas gift; Initial information received on 31-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-healthcare professional.  This case involves an unknown age and unknown gender patient who got covid n flu as a christmas gift after receiving vaccine Influenza Vaccine.  The patient's past medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.    On Nov, the patient received unknown dose of suspect Influenza Vaccine produced by unknown manufacturer lot (number, strength, formulation, expiry date not reported) via unknown route in unknown administration site for Influenza immunization.  On an unknown date the patient developed a non-serious event "got covid n flu as a christmas gift (covid-19) and (influenza)(unknown latency) following the administration of Influenza Vaccine.  It is unknown if there were lab data/results available.   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for both the events.    Outcome: Unknown for both the events.
Janssen COVID-19 Vaccine EUA  First day after getting the shot I got a feeling of being very tired throughout the day I did not feel like to do anything. Also my arm was very very sore. Even moving it slightly a bit would hurt. The second day is when things got way worse I could not really sleep that well throughout the night because I noticed I had  body aches in my legs and my back. Throughout that day I also felt like I had a fever in the morning I took my temperature and had a 100 fever. At night time I took my temperature and it went up to 102, with  still a bad headache, chills, and body aches throughout my legs mostly. I also felt some palpitations. When I went to bed I was sweating very prefusively all night that I had to change my shirt. On the third day I felt a lot better, still with a slight headache no fever, and still feeling like im sweating on and off.
long line that was 2 inches long and .5 inches wide at the injection site; warmness at the injection site; red blotches at the injection site; itching at the injection site; bruising at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (bruising at the injection site), VACCINATION SITE REACTION (long line that was 2 inches long and .5 inches wide at the injection site), VACCINATION SITE WARMTH (warmness at the injection site), RASH MACULAR (red blotches at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE BRUISING (bruising at the injection site). On an unknown date, the patient experienced VACCINATION SITE REACTION (long line that was 2 inches long and .5 inches wide at the injection site), VACCINATION SITE WARMTH (warmness at the injection site), RASH MACULAR (red blotches at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site). At the time of the report, VACCINATION SITE BRUISING (bruising at the injection site), VACCINATION SITE REACTION (long line that was 2 inches long and .5 inches wide at the injection site), VACCINATION SITE WARMTH (warmness at the injection site), RASH MACULAR (red blotches at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. No treatment information provided.
Sore arm following administration, resolved. Then on 2/17/21 arm sore again with hot sensation and red color. Still not resolved.
vial punctured for 24 hours; This spontaneous case was reported by a health care professional and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vial punctured for 24 hours) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044c21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vial punctured for 24 hours). At the time of the report, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vial punctured for 24 hours) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medication were reported no treatment information was provided
. On Friday 1/8/21, Pt was vaccinated with Moderna first dose in the left deltoid muscle.  No immediate issues/complications. Beginning Tuesday 1/19/21 (eleven days post-vaccine), she reports noticing itching in the injection site; no rash or other symptoms (e.g. temperature elevation, shortness of breath, wheezing, swelling, hives). Today 1/20/21 her arm has a noticeable ?rash? type reaction. She reports continued itching but no particular pain or tenderness. No visible pustules but the area is reddened and very slightly warm but not ?hot-to-touch?.  At about 4:15 pm, the affected area measured approximately 2 ¼ inches (5.5 cm) wide by 2 ½ inches (6.5 cm) long.   1/21/20, Pt reported taking oral diphenhydramine overnight /1/20/21) with reduced itching/swelling but again today notes return of redness, swelling and warm to touch. Pt reports about 3 years ago having a "tetanus" booster ? had a reaction of the entire upper arm with swelling, redness and hot-to touch.  No reported anaphylaxis. Based on consultation with the regional medical director, and the Infectious Disease Specialist, they will defer providing the second dose of Moderna.  Pt has been referred to her private health care provider with a recommendation to consider referral to an infectious disease practitioner for any future COVID-19 vaccine administration.
Began as sore arm L arm induration 20x25mm, erythema 30x50mm.
diagnosed with COVID; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (diagnosed with COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (diagnosed with COVID). At the time of the report, COVID-19 (diagnosed with COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment medications provided. The patient had her first two doses of Moderna COVID19 Vaccine on unknown dates, but theywere over 6 months ago.  Company comment: This case concerns a female patient of an unknown age, with no reported medical history, who experienced the non-serious, unexpected AESI event of Covid-19, more than 6 months after second dose of mRNA-1273 (Moderna COVID-19 Vaccine).  No further information was given. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a female patient of an unknown age, with no reported medical history, who experienced the non-serious, unexpected AESI event of Covid-19, more than 6 months after second dose of mRNA-1273 (Moderna COVID-19 Vaccine).  No further information was given. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.
right after vaccine(April 7): chills, dizziness day after vaccine(April 8):headache, sore throat, chills, shortness of breath, lightheadedness dizziness varying in intensity by day until today(April 9-22):shortness of breath, lightheadedness, dizziness
1025 pt c/o dizziness, sweating. b/p 131/77 hr 71 pulse ox 98%. placed on stretcher. 1030 b/p 146/98 hr 80 pulse ox 98%. 1043 pt up walking around. b/p 139/83 hr 75 pulse ox 97% 1045 pt discharged fromn site
Headache, Sedation, Myalgia, Arthralgia, Fever, Diarrhea, NauseaVomiting, Chills, swollen glands, pain at the injection site Narrative:
Child had received #3 HPV on 08-04-2016 at clinic. She stated she felt dizzy and nauseated about 20 minutes after getting home and this feeling continued for at least a week. Child said felt almost like having the flu.
I stopped getting my period; then bled for apporiximately one day after the second shot; and then stopped getting my period for approximately three months; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right (Lot number: EW0175) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Lot number: EW0186, Vaccine location: Right Arm), for Covid-19 Immunization. The following information was reported: MENSTRUAL DISORDER (non-serious) with onset 22May2021 18:00, outcome "recovered with sequelae", described as "I stopped getting my period; then bled for apporiximately one day after the second shot; and then stopped getting my period for approximately three months". Therapeutic measures were not taken as a result of menstrual disorder.  Additional information: Patient was not COVID prior vaccination and did not test for COVID post vaccination. Patient had no Known allergies.   No follow-up attempts are possible. No further information is expected.
Patient reported some neuropathy symptoms in his left leg including temperature sensation difference/sciatica pain 1-2 weeks post vaccination that have continued.
Lymph node swelled to size of a lime under my left armpit for 5 days.
8/27/2018 Patient fainted after vaccine and became pale, drooling, and motionless for several minutes before waking up. Drank Gatorade at doctors office and waited 30mins. before left office. Patient did not feel well after leaving and has become worse with several symptoms; Dizziness, headaches, extreme tiredness, brain fog, memory loss, blurry vision, tingling in hands and feet, pale color to skin, sleep issues, and mini catatonic seizures. The symptoms have occurred for 5 weeks and others symptoms have gotten worse, now with siezures. This still continues today 10/1/2018.